Prot #INCB18424-MA-GD-301: An Open-Label, Expanded Access Program of Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant
- Frankfurt, Olga (PD/PI)
Project: Research project
Project: Research project